REYON Pharmaceutical Co., Ltd. (KRX:102460)
South Korea · Delayed Price · Currency is KRW 10,040
-50 (-0.50%)
Sep 11, 2026, 3:30 PM KST
REYON Pharmaceutical Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 143,375 | 145,929 | 148,300 | 151,071 | 154,039 | 142,801 |
Revenue Growth | -4.45% | -1.60% | -1.84% | -1.93% | 7.87% | 9.82% |
Gross Profit Gross Profit Growth | 36,469 | 37,244 | 71,685 | 77,724 | 80,564 | 78,453 |
Operating Income Operating Income Growth | -30,256 | -31,562 | -985.46 | 1,773 | 4,448 | 1,545 |
Net Income Net Income Growth | -34,245 | -29,633 | 4,151 | 3,583 | 7,359 | 5,412 |
Earnings Per Share EPS Growth | -1867.11 | -1615.68 | 226.34 | 195.00 | 407.18 | 305.00 |
EPS Growth | - | - | 16.07% | -52.11% | 33.50% | 35.10% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Republic of Korea Republic of Korea Growth | 142,119 | 144,315 | 146,654 | 149,518 | 151,665 | 140,894 |
Japan Japan Growth | 906.47 | 949.6 | 902.88 | 831 | 1,786 | 1,777 |
Thailand Thailand Growth | 73.7 | 34.6 | 33.36 | 32.7 | - | - |
Vietnam Vietnam Growth | 130.22 | 433.28 | 368.76 | 446.77 | 323.36 | - |
Other Other Growth | 36.86 | 52.3 | 174.29 | 75.42 | - | - |
Mongolia Mongolia Growth | - | 88.15 | 88.7 | 60.96 | 31.69 | 47.42 |
Chile Chile Growth | - | 55.91 | 77.33 | - | - | - |
Total Total Growth | 143,375 | 145,929 | 148,300 | 151,071 | 154,039 | 142,801 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 7,036 | 6,782 | 10,215 | 24,241 | 36,069 | 97,448 |
Total Debt Total Debt Growth | 216,853 | 216,115 | 204,053 | 225,054 | 210,203 | 207,314 |
Net Cash (Debt) Net Cash Growth | -209,816 | -209,333 | -193,838 | -200,813 | -174,134 | -109,866 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -11439.74 | -11413.42 | -10568.57 | -10948.85 | -9538.14 | -6200.33 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 6,222 | 1,457 | -1,436 | 8,645 | 8,729 | 11,685 |
Capital Expenditures CapEx Growth | -5,045 | -7,916 | -16,012 | -28,870 | -63,133 | -116,978 |
Free Cash Flow Free Cash Flow Growth | 1,178 | -6,459 | -17,448 | -20,225 | -54,404 | -105,293 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 25.44% | 25.52% | 48.34% | 51.45% | 52.30% | 54.94% |
Operating Margin | -21.10% | -21.63% | -0.66% | 1.17% | 2.89% | 1.08% |
Pretax Margin | -22.50% | -16.87% | 3.48% | 2.67% | 4.48% | 4.09% |
Profit Margin | -23.89% | -20.31% | 2.80% | 2.37% | 4.78% | 3.79% |
FCF Margin | 0.82% | -4.43% | -11.77% | -13.39% | -35.32% | -73.73% |
| Fiscal Year | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 150.000 | 150.000 | 250.000 |
Dividend Per Share Growth | 0% | -40.00% | 25.00% |
Dividend Yield | 0.91% | 0.70% | 0.71% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 56.73 | 84.66 | 52.23 | 116.61 |
PS Ratio | 1.28 | 1.36 | 1.59 | 2.01 | 2.50 | 4.42 |